
Paratek Pharmaceuticals Investor Relations Material
Latest events

Q1 2023
Paratek Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Paratek Pharmaceuticals Inc
Access all reports
Paratek Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of innovative therapies for infectious diseases. The company specializes in antibiotics that address serious bacterial infections, including drug-resistant strains. Paratek's products are designed to provide effective treatment options for conditions such as skin infections and community-acquired bacterial pneumonia. The company is headquartered in Boston, Massachusetts, and its shares are listed on the NASDAQ.
Latest articles
)
James Quincey: Coca-Cola Chairman and CEO
James Quincey has dedicated nearly three decades to The Coca-Cola Company, rising through the ranks to become CEO and Chairman of the company.
11 Mar 2025
)
PepsiCo: From Pepsi and Gatorade to Doritos and Lay's
PepsiCo has grown from a soda company into a global leader in food and beverages, with a portfolio of over 200 brands, including Pepsi, Lay's, and Gatorade.
11 Mar 2025
)
Bob Iger: Disney's Visionary CEO
Bob Iger is a legend in the entertainment industry, known for his visionary leadership and as one of the most influential CEOs in Disney's history.
10 Mar 2025
Ticker symbol
PRTK
Country
🇺🇸 United States